Page last updated: 2024-08-22

nitroxoline and ceftazidime

nitroxoline has been researched along with ceftazidime in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Byrd, MS; Campos, CG; Clare, M; Cotter, PA; Hagen, TJ; Henderson, MW; Horn, JR; Masoudi, A; Myler, PJ; Wangtrakuldee, P; Zhang, Z	1
Brunst, S; Burgers, LD; Frank, D; Fürst, R; Gobec, S; Martinelli, G; Proschak, A; Proschak, E; Rotter, MJ; Sosič, I; Weizel, L; Wichelhaus, TA	1

Other Studies

2 other study(ies) available for nitroxoline and ceftazidime

Article	Year
Discovery of Inhibitors of ACS medicinal chemistry letters, 2013, Jul-01, Volume: 4, Issue:8 Topics:	2013
Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases. European journal of medicinal chemistry, 2022, Jan-15, Volume: 228 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroquinolines; Recombinant Proteins; Structure-Activity Relationship	2022

Article

Year

Discovery of Inhibitors of

ACS medicinal chemistry letters, 2013, Jul-01, Volume: 4, Issue:8

Topics:

2013

Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases.

European journal of medicinal chemistry, 2022, Jan-15, Volume: 228

Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroquinolines; Recombinant Proteins; Structure-Activity Relationship

2022